The PKM2 activator TEPP-46 suppresses kidney fibrosis via inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1α accumulation
| Image |  |
|---|---|
| Description | scientific article published on 12 December 2020 |
| Author/s |
author: Keizo Kanasaki Daisuke Koya |
| Publication date | December 12, 2020 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |